Astrana Health, Inc. (NASDAQ:ASTH) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Astrana Health, Inc. (NASDAQ:ASTH) has received an average rating of “Moderate Buy” from the nine brokerages that are covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $65.17.

Several analysts have recently commented on the stock. Robert W. Baird upped their price objective on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. TD Cowen assumed coverage on shares of Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 price objective for the company. Macquarie raised Astrana Health to a “hold” rating in a research report on Monday, December 16th. KeyCorp initiated coverage on Astrana Health in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. Finally, BTIG Research boosted their price objective on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a report on Thursday, October 3rd.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. GAMMA Investing LLC acquired a new stake in Astrana Health in the 3rd quarter valued at about $34,000. Nisa Investment Advisors LLC purchased a new stake in shares of Astrana Health during the third quarter worth approximately $35,000. KBC Group NV acquired a new stake in Astrana Health in the third quarter valued at approximately $70,000. Quarry LP purchased a new position in Astrana Health in the third quarter worth approximately $77,000. Finally, Quest Partners LLC purchased a new position in Astrana Health in the third quarter worth approximately $133,000. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Stock Performance

Shares of Astrana Health stock opened at $33.70 on Tuesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The business’s 50 day moving average price is $47.22 and its 200 day moving average price is $47.88. The company has a market cap of $1.90 billion, a price-to-earnings ratio of 25.92, a PEG ratio of 1.80 and a beta of 1.13. Astrana Health has a one year low of $33.44 and a one year high of $63.20.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting the consensus estimate of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $478.71 million for the quarter, compared to analysts’ expectations of $462.01 million. During the same quarter in the previous year, the company posted $0.47 EPS. On average, research analysts predict that Astrana Health will post 1.16 EPS for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.